Authors:
Schneider, LS
Tariot, PN
Lyketsos, CG
Dagerman, KS
Davis, KL
Davis, S
Hsiao, JK
Jeste, DV
Katz, IR
Olin, JT
Pollock, BG
Rabins, PV
Rosenheck, RA
Small, GW
Lebowitz, B
Lieberman, JA
Citation: Ls. Schneider et al., National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) - Alzheimer disease trial methodology, AM J GER PS, 9(4), 2001, pp. 346-360
Authors:
Tariot, PN
Schneider, LS
Mintzer, JE
Cutler, AJ
Cunningham, MR
Thomas, JW
Sommerville, KW
Citation: Pn. Tariot et al., Safety and tolerability of divalproex sodium in the treatment of signs andsymptoms of mania in elderly patients with dementia: Results of a double-blind, placebo-controlled trial, CURR THER R, 62(1), 2001, pp. 51-67
Authors:
Greene, YM
Tariot, PN
Wishart, H
Cox, C
Holt, CJ
Schwid, S
Noviasky, J
Citation: Ym. Greene et al., A 12-week, open trial of donepezil hydrochloride in patients with multiplesclerosis and associated cognitive impairments, J CL PSYCH, 20(3), 2000, pp. 350-356
Citation: Jl. Mack et al., Behavior rating scale for dementia: Development of test scales and presentation of data for 555 individuals with Alzheimer's disease, J GER PSY N, 12(4), 1999, pp. 211-223
Authors:
Tariot, PN
Jakimovich, LJ
Erb, R
Cox, C
Lanning, B
Irvine, C
Podgorski, CA
Citation: Pn. Tariot et al., Withdrawal from controlled carbamazepine therapy followed by further carbamazepine treatment in patients with dementia, J CLIN PSY, 60(10), 1999, pp. 684-689
Authors:
Tariot, PN
Upadhyaya, A
Sunderland, T
Cox, C
Cohen, RM
Murphy, DL
Loy, R
Citation: Pn. Tariot et al., Physiologic and neuroendocrine responses to intravenous naloxone in subjects with Alzheimer's disease and age-matched controls, BIOL PSYCHI, 46(3), 1999, pp. 412-419